INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation Australia - English - Department of Health (Therapeutic Goods Administration)

incruse ellipta umeclidinium (as bromide) 62.5 microgram powder for inhalation

glaxosmithkline australia pty ltd - umeclidinium bromide, quantity: 74.2 microgram (equivalent: umeclidinium, qty 62.5 microgram) - inhalation, powder for - excipient ingredients: magnesium stearate; lactose monohydrate - incruse ellipta is indicated as a long term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd)

ANORO ELLIPTA 62.5/25 umeclidinium (as bromide)/vilanterol (as trifenatate) 62.5 microgram/25 microgram powder for inhalation Australia - English - Department of Health (Therapeutic Goods Administration)

anoro ellipta 62.5/25 umeclidinium (as bromide)/vilanterol (as trifenatate) 62.5 microgram/25 microgram powder for inhalation

glaxosmithkline australia pty ltd - umeclidinium bromide, quantity: 74.2 microgram (equivalent: umeclidinium, qty 62.5 microgram); vilanterol trifenatate, quantity: 40 microgram (equivalent: vilanterol, qty 25 microgram) - inhalation, powder for - excipient ingredients: magnesium stearate; lactose monohydrate - anoro ellipta is indicated as a long-term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

INCRUSE ELLIPTA INHALATION POWDER 62.5 MCGDOSE Singapore - English - HSA (Health Sciences Authority)

incruse ellipta inhalation powder 62.5 mcgdose

glaxosmithkline pte ltd - umeclidinium bromide 74.2 mcg (micronised) eqv. umeclidinium - powder, metered - umeclidinium bromide 74.2 mcg (micronised) eqv. umeclidinium 62.5 mcg/dose

ANORO ELLIPTA Inhalation Powder Kenya - English - Pharmacy and Poisons Board

anoro ellipta inhalation powder

glaxosmithkline pharmaceutical kenya limited p.o. box 78392-00507, likoni road industrial - umeclidinium bromide and vilanterol trifenatate - inhalation powder - 62.5mcg/25mcg - vilanterol and umeclidinium bromide

Trelegy Ellipta 100/62.5/25 New Zealand - English - Medsafe (Medicines Safety Authority)

trelegy ellipta 100/62.5/25

glaxosmithkline nz limited - fluticasone furoate 100ug;  ; umeclidinium bromide 74.2ug equivalent to umeclidinium 62.5 mcg (free cation);  ; vilanterol trifenatate 40ug equivalent to 25 mcg of vilanterol (free base);   - powder for inhalation - active: fluticasone furoate 100ug   umeclidinium bromide 74.2ug equivalent to umeclidinium 62.5 mcg (free cation)   vilanterol trifenatate 40ug equivalent to 25 mcg of vilanterol (free base)   excipient: lactose monohydrate magnesium stearate - trelegy ellipta is indicated for the maintenance treatment of adults with moderate to severe chronic obstructive pulmonary disease (copd) who require treatment with a long-acting muscarinic receptor antagonist (lama) + long-acting beta2-receptor agonist (laba) + inhaled corticosteroid (ics). trelegy ellipta should not be used for the initiation of copd treatment.

Trelegy Ellipta 200/62.5/25 New Zealand - English - Medsafe (Medicines Safety Authority)

trelegy ellipta 200/62.5/25

glaxosmithkline nz limited - fluticasone furoate 200ug;  ; umeclidinium bromide 74.2ug equivalent to 62.5 mcg of umeclidinium (free cation);  ; vilanterol trifenatate 40ug equivalent to 25 mcg of vilanterol (free base);   - powder for inhalation - active: fluticasone furoate 200ug   umeclidinium bromide 74.2ug equivalent to 62.5 mcg of umeclidinium (free cation)   vilanterol trifenatate 40ug equivalent to 25 mcg of vilanterol (free base)   excipient: lactose monohydrate magnesium stearate - trelegy ellipta is indicated for the maintenance treatment of asthma in adult patients who are not adequately controlled with a combination of inhaled corticosteroid and a long-acting beta2-agonist.

ANORO ELLIPTA INHALATION POWDER 62.5 MCG25 MCG Singapore - English - HSA (Health Sciences Authority)

anoro ellipta inhalation powder 62.5 mcg25 mcg

glaxosmithkline pte ltd - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol - powder, metered - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium 62.5 mcg/dose; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol 25 mcg/dose

BRALTUS tiotropium (as bromide) 13 microgram powder for inhalation hard capsule Australia - English - Department of Health (Therapeutic Goods Administration)

braltus tiotropium (as bromide) 13 microgram powder for inhalation hard capsule

teva pharma australia pty ltd - tiotropium bromide, quantity: 15.6 microgram (equivalent: tiotropium, qty 13 microgram) - capsule, hard - excipient ingredients: lactose monohydrate - braltus is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd).,braltus is indicated for the prevention of copd exacerbations

INCRUSE™ ELLIPTA™ 62.5 United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

incruse™ ellipta™ 62.5

umeclidinium bromide micronised [74.2 micrograms of umeclidinium bromide is equivalent to 62.5 micrograms of umeclidinium (free cation)] -

Anoro Ellipta powder for inhalation Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

anoro ellipta powder for inhalation

glaxo operations uk ltd - umeclidinium (umeclidinium bromide), vilanterol (vilanterol trifenatate) - powder for inhalation - 62.5mcg/dose+ 25mcg/dose